Roberto Diaz, MD
Hand Surgery · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 3 carriers
- Offices
- 3
Offices
3 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Hospitals listed: El Camino Health. That is not proof they admit you there this week.
Plans that list them
3 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Diaz’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
3 of 3 plans
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A112035 · Current
Licensed to practise in California · since 2010 · expires 2027-09-30 · University of Iowa College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$156,951
Medicare paid this office $156,951 for 482 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 170 | $22,112 | $111 |
| New patient visit (45+ min) | 147 | $20,895 | $142 |
| Short return visit (20+ min) | 162 | $18,394 | $81 |
| New patient visit (30+ min) | 106 | $10,098 | $95 |
| Incision of tendon covering of finger | 13 | $8,797 | $550 |
See all 15 services
| Return visit (30+ min) | 170 | $22,112 | $111 |
| New patient visit (45+ min) | 147 | $20,895 | $142 |
| Short return visit (20+ min) | 162 | $18,394 | $81 |
| New patient visit (30+ min) | 106 | $10,098 | $95 |
| Incision of tendon covering of finger | 13 | $8,797 | $550 |
| Release and/or relocation of hand nerve | 12 | $6,169 | $411 |
| Injection into tendon or ligament | 75 | $4,801 | $49 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 13 | $2,016 | $155 |
| Aspiration and/or injection of fluid from small joint | 25 | $1,668 | $49 |
| Aspiration and/or injection of fluid from medium joint | 28 | $1,424 | $49 |
| Injection of carpal tunnel | 14 | $1,409 | $88 |
| Application of elbow to finger cast | 14 | $1,230 | $88 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 114 | $321 | None |
| Cast supplies, short arm cast, adult (11 years +), fiberglass | 13 | $242 | $19 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 34 | $221 | None |
Procedures Medicare counted
| Removal of nail tissue | 1-10 | None |
| Removal of tissue | 1-10 | None |
| Upper limb (arm) arthroscopy (minimally invasive joint repair) | 1-10 | None |
Who their Medicare patients are
482 Original Medicare patients in 2024. Average age 76 · Under 65 2% · 85 and older 15% · Women 60% · Also on Medicaid 8% · Health risk score 0.87. At or below the middle of the specialty; the typical hand surgery clinician is at 1.08.
Conditions among them: High blood pressure 59% · Diabetes 22% · Coronary heart disease 20% · Chronic kidney disease 17% · Atrial fibrillation 16% · Depression 16% · Cancer 15% · Heart failure 10% · COPD 7% · Stroke 5% · Dementia 4%.
The office billed $682,737, Medicare allowed $208,598 and paid $156,951; for 1,544 services of 68 kinds; $542 of it was for drugs given in the office and $156,408 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 482 | 1,544 | 76 | 0.87 | $682,737 | $156,951 |
| 2023 | 471 | 1,244 | 76 | 0.93 | $658,050 | $162,182 |
| 2022 | 446 | 1,235 | 76 | 0.95 | $585,984 | $149,860 |
| 2021 | 358 | 1,088 | 76 | 0.99 | $587,334 | $154,685 |
| 2020 | 309 | 847 | 75 | 1.01 | $397,719 | $95,924 |
| 2019 | 382 | 1,120 | 75 | 1.20 | $520,990 | $123,916 |
| 2018 | 353 | 1,098 | 75 | 1.00 | $500,753 | $120,152 |
| 2017 | 300 | 997 | 76 | 1.10 | $399,453 | $94,291 |
| 2016 | 209 | 593 | 75 | 1.10 | $250,562 | $62,403 |
| 2015 | 114 | 286 | 74 | 1.36 | $178,927 | $31,449 |
| 2014 | 68 | 84 | 70 | 1.12 | $111,127 | $7,272 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 13 services
| Return visit (30+ min) | 194 | $26,953 | $115 |
| New patient visit (45+ min) | 182 | $26,521 | $146 |
| Incision of tendon covering of finger | 19 | $12,851 | $612 |
| Short return visit (20+ min) | 111 | $12,380 | $81 |
| Release and/or relocation of hand nerve | 21 | $10,239 | $427 |
| Injection into tendon or ligament | 98 | $6,345 | $55 |
| New patient visit (30+ min) | 60 | $5,805 | $97 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 14 | $2,239 | $160 |
| Aspiration and/or injection of fluid from small joint | 26 | $1,399 | $50 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 132 | $1,086 | None |
| Application of elbow to finger cast | 11 | $1,085 | $90 |
| Cast supplies, short arm cast, adult (11 years +), fiberglass | 11 | $218 | $18 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 18 | $41 | None |
2022: 13 services
| New patient visit (45+ min) | 183 | $27,070 | $148 |
| Return visit (30+ min) | 187 | $26,782 | $111 |
| Short return visit (20+ min) | 111 | $12,775 | $83 |
| Incision of tendon covering of finger | 18 | $11,891 | $626 |
| Release and/or relocation of hand nerve | 16 | $6,855 | $428 |
| New patient visit (30+ min) | 68 | $6,697 | $98 |
| Injection into tendon or ligament | 94 | $6,180 | $52 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 11 | $1,993 | $181 |
| Aspiration and/or injection of fluid from small joint | 30 | $1,562 | $50 |
| Application of elbow to finger cast | 14 | $1,222 | $87 |
| Aspiration and/or injection of fluid from medium joint | 19 | $1,114 | $53 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 138 | $903 | None |
| Cast supplies, short arm cast, adult (11 years +), fiberglass | 13 | $218 | $17 |
2021: 14 services
| New patient visit (45+ min) | 164 | $24,869 | $152 |
| Return visit (30+ min) | 157 | $24,399 | $121 |
| Short return visit (20+ min) | 97 | $11,682 | $87 |
| Incision of tendon covering of finger | 13 | $8,417 | $601 |
| Release and/or relocation of hand nerve | 16 | $7,188 | $423 |
| Injection into tendon or ligament | 83 | $4,996 | $51 |
| New patient visit (30+ min) | 45 | $4,064 | $90 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 20 | $3,564 | $178 |
| Application of elbow to finger cast | 12 | $1,061 | $82 |
| Aspiration and/or injection of fluid from medium joint | 14 | $827 | $55 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 111 | $754 | None |
| Aspiration and/or injection of fluid from small joint | 14 | $745 | $50 |
| Cast supplies, short arm cast, adult (11 years +), fiberglass | 12 | $196 | $15 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 13 | $46 | None |
2020: 9 services
| Short return visit (20+ min) | 125 | $13,795 | $71 |
| Return visit (30+ min) | 136 | $12,939 | $90 |
| Incision of tendon covering of finger | 18 | $9,844 | $547 |
| New patient visit (30+ min) | 96 | $8,746 | $91 |
| Injection into tendon or ligament | 60 | $4,007 | $48 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 13 | $2,464 | $190 |
| Aspiration and/or injection of fluid from small joint | 16 | $846 | $45 |
| Short return visit | 11 | $824 | $46 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 86 | $663 | None |
2019: 12 services
| Short return visit (20+ min) | 176 | $17,350 | $65 |
| Return visit (30+ min) | 153 | $15,989 | $96 |
| New patient visit (30+ min) | 139 | $12,615 | $91 |
| Incision of tendon covering of finger | 18 | $11,067 | $553 |
| Injection into tendon or ligament | 73 | $4,562 | $44 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 21 | $3,870 | $184 |
| Application of elbow to finger cast | 20 | $1,854 | $84 |
| Aspiration and/or injection of fluid from small joint | 22 | $1,117 | $41 |
| Injection of carpal tunnel | 12 | $1,066 | $71 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 114 | $766 | None |
| Aspiration and/or injection of fluid from medium joint | 13 | $632 | $45 |
| Cast supplies, short arm cast, adult (11 years +), fiberglass | 20 | $330 | $16 |
2018: 10 services
| Return visit (30+ min) | 172 | $17,850 | $92 |
| Short return visit (20+ min) | 149 | $14,988 | $65 |
| Incision of tendon covering of finger | 18 | $11,514 | $548 |
| New patient visit (30+ min) | 121 | $10,832 | $90 |
| Release and/or relocation of hand nerve | 14 | $6,521 | $384 |
| Injection into tendon or ligament | 76 | $4,980 | $44 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 13 | $2,221 | $171 |
| Aspiration and/or injection of fluid from small joint | 21 | $1,249 | $42 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 102 | $896 | None |
| Aspiration and/or injection of fluid from medium joint | 15 | $816 | $43 |
2017: 9 services
| Return visit (30+ min) | 141 | $14,259 | $91 |
| Short return visit (20+ min) | 149 | $14,139 | $63 |
| New patient visit (30+ min) | 102 | $9,771 | $96 |
| Injection into tendon or ligament | 61 | $3,921 | $44 |
| Aspiration and/or injection of fluid from medium joint | 17 | $990 | $47 |
| Aspiration and/or injection of fluid from small joint | 16 | $786 | $44 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 91 | $743 | None |
| Injection of drug or substance under skin or into muscle | 14 | $362 | $24 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 14 | $70 | None |
2016: 6 services
| Short return visit (20+ min) | 111 | $12,101 | $64 |
| Return visit (30+ min) | 79 | $7,957 | $96 |
| New patient visit (30+ min) | 67 | $5,939 | $89 |
| Injection into tendon or ligament | 26 | $1,627 | $48 |
| Aspiration and/or injection of fluid from small joint | 11 | $455 | $38 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 34 | $205 | None |
2015: 4 services
| Short return visit (20+ min) | 50 | $5,433 | $71 |
| New patient visit (30+ min) | 33 | $3,267 | $99 |
| Injection into tendon or ligament | 20 | $1,584 | $57 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 25 | $162 | None |
2014: 3 services
| Prosthetic repair of shoulder joint, total shoulder | 12 | $2,524 | $210 |
| Short return visit (20+ min) | 33 | $1,594 | $46 |
| New patient visit (30+ min) | 11 | $743 | $68 |
Drugs they prescribed that Part D paid
$382
Pharmacies billed $382 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 58% of their Part D prescriptions (46 of 80) in 2024. Above the middle of the specialty; the typical hand surgery clinician is at 47%.
80 generic and 0 brand-name prescriptions · $382 in drug cost · 12 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Hydrocodone-Acetaminophen | 33 | $175 | $5 |
| Ibuprofen | 15 | $21 | $1 |
Year by year
| 2024 | 80 | 51 | 58% (46) | 0% | $382 |
| 2023 | 100 | 64 | 56% (56) | None | $487 |
| 2022 | 73 | 50 | 47% (34) | 0% | $400 |
| 2021 | 100 | 65 | 48% (48) | None | $696 |
| 2020 | 80 | 53 | 56% (45) | 0% | $564 |
| 2019 | 90 | 62 | 48% (43) | None | $1,244 |
| 2018 | 168 | 107 | 41% (68) | 10% | $2,174 |
| 2017 | 66 | 43 | 55% (36) | None | $679 |
| 2016 | 66 | 43 | 44% (29) | None | $601 |
| 2015 | 42 | 30 | 60% (25) | None | $536 |
| 2014 | 38 | 29 | 71% (27) | None | $663 |
| 2013 | 35 | 23 | 66% (23) | None | $760 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 2 drugs
| Hydrocodone-Acetaminophen | 47 | $186 | $4 |
| Ibuprofen | 22 | $59 | $3 |
2022: 2 drugs
| Hydrocodone-Acetaminophen | 26 | $107 | $4 |
| Ibuprofen | 20 | $48 | $2 |
2021: 2 drugs
| Hydrocodone-Acetaminophen | 40 | $180 | $5 |
| Ibuprofen | 14 | $32 | $2 |
2020: 3 drugs
| Hydrocodone-Acetaminophen | 22 | $115 | $5 |
| Acetaminophen-Codeine | 21 | $75 | $4 |
| Cephalexin | 11 | $35 | $3 |
2019: 3 drugs
| Diclofenac | 11 | $337 | $31 |
| Hydrocodone-Acetaminophen | 28 | $155 | $6 |
| Gabapentin | 11 | $99 | $9 |
2018: 6 drugs
| Diclofenac | 18 | $622 | $35 |
| Hydrocodone-Acetaminophen | 30 | $155 | $5 |
| Oxycodone | 16 | $112 | $7 |
| Cephalexin | 13 | $94 | $7 |
| Ibuprofen | 11 | $38 | $3 |
| Acetaminophen-Codeine | 16 | $36 | $2 |
2017: 1 drug
| Hydrocodone-Acetaminophen | 16 | $84 | $5 |
2016: 2 drugs
| Hydrocodone-Acetaminophen | 14 | $176 | $13 |
| Gabapentin | 15 | $78 | $5 |
2014: 1 drug
| Oxycodone | 11 | $137 | $12 |
Money from drug and device companies
$230 in 2025
| 2025 | 2 | 3 | None | $230 |
| 2024 | 2 | 3 | None | $221 |
| 2020 | 1 | 1 | None | $32 |
| 2019 | 1 | 2 | None | $49 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
See all 3 published payments
| Axogen | Meals · 2025-12-03 | None | $149 |
| Axogen | Meals · 2025-09-29 | None | $55 |
| Endo USA | Meals · 2025-07-11 | Xiaflex | $26 |
See earlier years (2024, 2020, 2019)
2024: $221
| Globus Medical | Excelsius Deformity | $174 | 2 payments
|
| Axogen | Avance Nerve Graft | $47 | 1 payment
|
2020: $32
| Axogen | Avance Nerve Graft | $32 | 1 payment
|
2019: $49
| Axogen | Axoguard Nerve Connector | $49 | 2 payments
|
Professional record
- NPI
- 1124261110
- Licence
- CA A112035California A112035: Current · expires 2027-09-30
- Trained
- University of Iowa, Rj & L Carver College of Medicine, 2008
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207XS0106X (207XS0106X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2009-04-07
- NPI last updated
- 2020-12-10
- NPI record certified
- 2020-12-10
This is when the NPI record was last certified, not a medical board exam.